EVAX

Evaxion Biotech AS (EVAX) is a pioneering clinical-stage biopharmaceutical company based in Hørsholm, Denmark, leveraging advanced artificial intelligence to drive innovation in immunotherapy. With a strategic focus on addressing unmet medical needs in oncology, bacterial diseases, and viral infections, the company utilizes its proprietary platform to identify and develop novel therapeutic candidates. As Evaxion progresses its diverse pipeline, it aims to transform treatment paradigms and enhance patient outcomes, establishing itself as a significant force within the biotechnology industry.